All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: Cell line-24758333

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	24758333	460insD	Env	Env	Cell line	G R S	View
2	24758333	D185E	Env	Env	Cell line	G R S	View
3	24758333	D185G	Env	Env	Cell line	G R S	View
4	24758333	D185N	Env	Env	Cell line	G R S	View
5	24758333	delNIND	Env	Env	Cell line	G R S	View
6	24758333	E185D	Env	Env	Cell line	G R S	View
7	24758333	G185D	Env	Env	Cell line	G R S	View
8	24758333	H144L	Env	Env	Cell line	G R S	View
9	24758333	I190T	Env	Env	Cell line	G R S	View
10	24758333	I467T	gp120	Env	Cell line	G R S	View
11	24758333	N185D	Env	Env	Cell line	G R S	View
12	24758333	N186Q	Env	Env	Cell line	G R S	View
13	24758333	N189S	Env	Env	Cell line	G R S	View
14	24758333	N197Q	Env	Env	Cell line	G R S	View
15	24758333	N301Q	Env	Env	Cell line	G R S	View
16	24758333	N339Q	Env	Env	Cell line	G R S	View
17	24758333	N386Q	Env	Env	Cell line	G R S	View
18	24758333	N392Q	Env	Env	Cell line	G R S	View
19	24758333	R500M	Env	Env	Cell line	G R S	View
20	24758333	V488I	Env	Env	Cell line	G R S	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.